Duncan Whitney Joins US Genomics as VP of R&D, Samuel Broder Tapped as New Director of Protein Design Labs, Daniel Von Hoff Joins SAB of Spectrum Pharmaceuticals, Greg Lucier Becomes Trustee of Burnham Institute, and Others

Duncan Whitney has become vice president of research and development at US Genomics, the company said last week. He joins US Genomics from Exact Sciences, where he was vice president of technology. Prior to that, he held senior management positions at Molecular Geodesics, PerSeptive Biosystems, and Polaroid. Whitney has a PhD in polymer sciences from the Massachusetts Institute of Technology and a BS in chemistry from ColbyCollege.

Samuel Broder has joined the board of directors of Protein Design Labs, the Fremont, Calif.-based company said yesterday. He is the chief medical officer of Celera Genomics and Celera Diagnostics. Prior to that, he was senior vice president for research and development at Ivax, and before that, director of the National Cancer Institute. Broder has a medical degree and a bachelor's degree from the Universityof Michigan.

Daniel Von Hoff has joined the scientific advisory board of Spectrum Pharmaceuticals, the Irvine, Calif.-based company said on Monday. He is a senior investigator and head of translational research at the Translational Genomics Research Institute in Arizona. He is also the chief scientific officer for US Oncology.

David Owen has been appointed as a non-executive director of Oxford Gene Technology, the company said this week. He is the non-executive chairman of Abcellute and of the Cardiff Partnership Fund as well as co-chairman of EMBL EnterpriseManagement. Owen holds a PhD in pharmacology.

Greg Lucier has become a member of the board of trustees of the Burnham Institute, the La Jolla, Calif.-based institute said last week. He is president and chief executive officer of Invitrogen.

Dennis "Mickey" Flynn will become president of the Pennsylvania Bio Board, effective Nov.1, the bioscience industry organization said last week. He will succeed Fritz Bittenbender, who will become senior director of corporate affairs at Cephalon. Flynn joins Pennsylvania Bio from Puresyn, where he was president.

Thomas Joos and Forest White have joined the scientific advisory board of Epitome Biosystems, the Waltham, Mass.-based company said last week. Joos is head of the biochemistry department at the NMI Natural and Medical Sciences Institute at the Universityof T bingen in Germany. White is an assistant professor in the division of biological engineering at the Massachusetts Institute of Technology.

Peter Schultz has joined the board of directors of Nanosphere, the Northbrook, Ill.-based company said last week. He is professor of chemistry at the Scripps Research Institute as well as director of the Genomics Institute of the Novartis Research Foundation, also based in La Jolla. In addition, Schultz is a founder of Affymax Research Institute, Symyx Technologies, Ambrx, Syrrx, Kalypsys, Phenomix, and Ilypsa. He holds a doctoral and a bachelor's degree from the California Institute of Technology.

Ted Love has been appointed as chairman of the board of directors of Nuvelo, the company said last week. He is the president and CEO of Nuvelo. Love replaces George Rathmann, who will remain on the board as chairman emeritus.

In addition, Barry Zubrow, currently vice chairman of Nuvelo's board, will also become the lead independent director.

Vicki Chandler and Titia de Lange are among the 13 winners of the 2005 NIH Director's Pioneer Award announced by the National Institutes of Health last week. The award, which comes with $2.5 million in direct costs over five years, supports "exceptionally creative scientists who take innovative approaches to major challenges in biomedical research," according to NIH. Chandleris a professor of plant sciences and molecular and cellular biology at the Universityof Arizona in Tucson, where she studies the control of gene expression. De Lange is a professor and head of the laboratory of cell biology and genetics at RockefellerUniversity, where she studies telomeres.

Promoted? Changing jobs? GenomeWeb News wants to know. E-mail us at   [email protected] to announce your move in PEOPLE, a weekly roundup of personnel changes in the genomics industry.